| Olaparib for Metastatic Breast Cancer in Patients with a Germline BRCA Mutation M Robson, SA Im, E Senkus, B Xu, SM Domchek, N Masuda, S Delaloge, ... New England Journal of Medicine 377 (6), 523-533, 2017 | 3036 | 2017 |
| Oral poly (ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial A Tutt, M Robson, JE Garber, SM Domchek, MW Audeh, JN Weitzel, ... The Lancet 376 (9737), 235-244, 2010 | 2171 | 2010 |
| Olaparib Monotherapy in Patients With Advanced Cancer and a Germline BRCA1/2 Mutation B Kaufman, R Shapira-Frommer, RK Schmutzler, MW Audeh, ... Journal of clinical oncology 33 (3), 244-250, 2015 | 1912 | 2015 |
| Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality SM Domchek, TM Friebel, CF Singer, DG Evans, HT Lynch, C Isaacs, ... Jama 304 (9), 967-975, 2010 | 1704 | 2010 |
| Meta-analysis of risk reduction estimates associated with risk-reducing salpingo-oophorectomy in BRCA1 or BRCA2 mutation carriers TR Rebbeck, ND Kauff, SM Domchek Journal of the National Cancer Institute 101 (2), 80-87, 2009 | 1132 | 2009 |
| Adjuvant Olaparib for Patients with BRCA1- or BRCA2-Mutated Breast Cancer ANJ Tutt, JE Garber, B Kaufman, G Viale, D Fumagalli, P Rastogi, ... New England Journal of Medicine 384 (25), 2394-2405, 2021 | 1091 | 2021 |
| Breast-Cancer Risk in Families with Mutations in PALB2 AC Antoniou, S Casadei, T Heikkinen, D Barrowdale, K Pylkäs, J Roberts, ... New England Journal of Medicine 371 (6), 497-506, 2014 | 1090 | 2014 |
| Gene-panel sequencing and the prediction of breast-cancer risk DF Easton, PDP Pharoah, AC Antoniou, M Tischkowitz, SV Tavtigian, ... New England Journal of Medicine 372 (23), 2243-2257, 2015 | 1021 | 2015 |
| Central nervous system metastases in women who receive trastuzumab‐based therapy for metastatic breast carcinoma JC Bendell, SM Domchek, HJ Burstein, L Harris, J Younger, I Kuter, ... Cancer 97 (12), 2972-2977, 2003 | 963 | 2003 |
| Pathology of breast and ovarian cancers among BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA) N Mavaddat, D Barrowdale, IL Andrulis, SM Domchek, D Eccles, ... Cancer Epidemiology, Biomarkers & Prevention 21 (1), 134-147, 2012 | 774 | 2012 |
| Risk-reducing salpingo-oophorectomy for the prevention of BRCA1-and BRCA2-associated breast and gynecologic cancer: a multicenter, prospective study ND Kauff, SM Domchek, TM Friebel, ME Robson, J Lee, JE Garber, ... Journal of clinical oncology 26 (8), 1331-1337, 2008 | 712 | 2008 |
| OlympiAD final overall survival and tolerability results: Olaparib versus chemotherapy treatment of physician’s choice in patients with a germline BRCA mutation and HER2 … ME Robson, N Tung, P Conte, SA Im, E Senkus, B Xu, N Masuda, ... Annals of Oncology 30 (4), 558-566, 2019 | 676 | 2019 |
| Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer SE Bojesen, KA Pooley, SE Johnatty, J Beesley, K Michailidou, JP Tyrer, ... Nature genetics 45 (4), 371-384, 2013 | 650 | 2013 |
| Genetic/familial high-risk assessment: breast, ovarian, and pancreatic, version 2.2021, NCCN clinical practice guidelines in oncology MB Daly, T Pal, MP Berry, SS Buys, P Dickson, SM Domchek, ... Journal of the National Comprehensive Cancer Network 19 (1), 77-102, 2021 | 634 | 2021 |
| A population-based study of genes previously implicated in breast cancer C Hu, SN Hart, R Gnanaolivu, H Huang, KY Lee, J Na, C Gao, J Lilyquist, ... New England Journal of Medicine 384 (5), 440-451, 2021 | 616 | 2021 |
| American Society of Clinical Oncology policy statement update: genetic and genomic testing for cancer susceptibility ME Robson, AR Bradbury, B Arun, SM Domchek, JM Ford, HL Hampel, ... Journal of Clinical Oncology 33 (31), 3660-3667, 2015 | 592 | 2015 |
| Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer TR Rebbeck, N Mitra, F Wan, OM Sinilnikova, S Healey, L McGuffog, ... Jama 313 (13), 1347-1361, 2015 | 560 | 2015 |
| Multidisciplinary meeting on male breast cancer: summary and research recommendations LA Korde, JA Zujewski, L Kamin, S Giordano, S Domchek, WF Anderson, ... Journal of clinical oncology 28 (12), 2114-2122, 2010 | 555 | 2010 |
| American Society of Clinical Oncology policy statement update: genetic and genomic testing for cancer susceptibility ME Robson, CD Storm, J Weitzel, DS Wollins, K Offit Journal of clinical oncology 28 (5), 893-901, 2010 | 553 | 2010 |
| Effect of Short-Term Hormone Replacement Therapy on Breast Cancer Risk Reduction After Bilateral Prophylactic Oophorectomy in BRCA1 and BRCA2 Mutation … TR Rebbeck, T Friebel, T Wagner, HT Lynch, JE Garber, MB Daly, ... Journal of clinical oncology 23 (31), 7804-7810, 2005 | 541 | 2005 |
